Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19

Supplemental Digital Content is available in the text.

[1]  V. Regitz-Zagrosek,et al.  Impact of sex and gender on COVID-19 outcomes in Europe , 2020, Biology of Sex Differences.

[2]  V. Fuster,et al.  Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 , 2020, Journal of the American College of Cardiology.

[3]  P. Theocharis,et al.  Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.

[4]  A. Iwasaki,et al.  The potential danger of suboptimal antibody responses in COVID-19 , 2020, Nature Reviews Immunology.

[5]  Yan-ling Ma,et al.  Antibody Detection and Dynamic Characteristics in Patients with COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Kaijun Jiang,et al.  SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup , 2020, Current protocols in microbiology.

[7]  S. Pastores,et al.  Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019 , 2020, Critical care explorations.

[8]  G. Fonarow,et al.  Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. , 2020, JAMA cardiology.

[9]  D. Annane,et al.  Immune Effects of Corticosteroids in Sepsis , 2018, Front. Immunol..

[10]  C. Tschöpe,et al.  Inflammation – Cause or Consequence of Heart Failure or Both? , 2017, Current Heart Failure Reports.